What does cardiometabolic health mean and what does it include?

Cardiometabolic health refers to the combined state of cardiovascular and metabolic systems — heart function, blood pressure, blood sugar regulation, cholesterol metabolism, and body weight. These systems are deeply interconnected: insulin resistance raises cardiovascular risk, and chronic inflammation accelerates arterial damage. Cardiometabolic health is monitored through blood biomarkers and increasingly informed by genetic variants that influence each pathway.

What genetic variants most influence cholesterol and cardiovascular risk?

APOE genotype is among the most studied cardiovascular variants — APOE4 carriers have elevated LDL and increased cardiovascular and cognitive risk. CETP variants influence HDL levels and reverse cholesterol transport. PCSK9 variants affect LDL receptor activity and cholesterol clearance. MTHFR variants elevate homocysteine, a recognized cardiovascular risk factor. Together, these explain why two people on identical diets can have very different cholesterol profiles.

How does inflammation contribute to cardiovascular disease at the genetic level?

Chronic low-grade inflammation damages arterial walls independently of LDL cholesterol. Variants in IL-6, TNF-alpha, and CRP genes influence baseline inflammatory tone and how aggressively inflammation responds to diet and stress triggers. Individuals with pro-inflammatory variants may have elevated hsCRP and accelerated arterial plaque progression even when standard cholesterol panels appear normal — making inflammatory markers a critical part of complete cardiometabolic assessment.

What is the connection between blood sugar regulation and heart health?

Insulin resistance directly raises cardiovascular risk through elevated triglycerides, reduced HDL, increased small dense LDL, and systemic inflammation. TCF7L2, PPARG, and KCNJ11 variants influence insulin sensitivity and type 2 diabetes risk. Because metabolic and cardiovascular systems are tightly linked, monitoring HbA1c and fasting glucose alongside lipid markers provides a more complete cardiometabolic risk picture than cholesterol measurements alone.

Can at-home testing meaningfully monitor cardiometabolic health?

Yes, within appropriate scope. At-home blood tests accurately measure the core cardiometabolic biomarkers — HbA1c, fasting glucose, full lipid panel, and hsCRP — that form the foundation of cardiometabolic monitoring. Pairing these results with genetic data identifying your cardiovascular variants creates a dual-layer view: your current biomarker status plus your inherited risk profile. This combination supports proactive wellness monitoring, not clinical diagnosis.

Cardiometabolic Health & Genetics

Cardiometabolic Genetics Explained

Your cardiovascular and metabolic systems are deeply interconnected — and your genetics play a role in how both function over time. Variants in genes related to lipid metabolism, blood pressure regulation, inflammation response, and insulin sensitivity can influence your cardiometabolic tendencies in ways that are fixed in your DNA but highly responsive to lifestyle.

This hub contains the individual genetic insights from the PlexusDx Cardiometabolic Genetic Report — each page interpreting a specific variant and its connection to cardiovascular function, metabolic balance, or inflammatory pathways. Results are delivered through your PlexusDx Results Portal alongside personalized diet, supplement, and lifestyle recommendations.

The Cardiometabolic Genetic Report is included with the Longevity & Healthy Aging Genetic Test and the Precision Functional Health Genetic Test — two of PlexusDx's most comprehensive options for understanding long-term health.

For education and wellness purposes only — not intended to diagnose or treat any condition.

Explore the Longevity & Healthy Aging Genetic Test

Your cart is currently empty.

Cardiometabolic

Cardiometabolic Genetics Explained

Frequently Asked Questions